Le Lézard
Classified in: Health, Business
Subjects: ACC, TRI

James Ahern Leads Laidlaw Venture Partners to Secure PIPE Financing for Odyssey


Pairing to Facilitate Odyssey Concussion Study and Enhance Shareholder Value

New York , June 8, 2022 /PRNewswire/ -- Health-tech focused venture capital firm, Laidlaw Venture Partners is pleased to announce it has secured PIPE financing for Odyssey Group, one of the world's leading providers of reinsurance.

The investment banking experts plan to partner with Odyssey as its advisor to enhance shareholder value and ultimately take the company public on the Nasdaq.  

The financing will assist Odyssey in completing its Phase 1 study of their concussion drug, which will test its safety amongst human patients and enable the company to advance into their Phase 2, in conjunction with the NCAA and Department of Defense, to prove its effectiveness. The intranasal treatment can be administered on-site to those who have sustained a concussion in an effort to mitigate any long-term effects ? e.g., to athletes or soldiers.

Founder of Laidlaw Venture Partners, James Ahern said; "Research suggests that combat soldiers are extremely likely to suffer from concussions due to the hazardous nature of their duties. On-the-spot treatment for these situations is imperative in potentially limiting the repercussion of sustaining concussion long-term. We are honored to work alongside Odyssey's Military Advisory Board and are hopeful to have the opportunity to work with military training center, Camp Shelby and army base, Fort Bragg in their Phase 2 trial later this year. It is our privilege to be able to play a role in supporting our heroes."

Odyssey's newly formed Military Advisory Board is led by esteemed current and ex-Military leaders including Dallas Hack, James Linder, Francis Beaudette, Timothy Szymanski and Paul Toolan.

Laidlaw Venture Partners will also be working alongside Odyssey's Athletic Advisory Board, led by Kurt Warner, Brett Favre, Mark Rypien and Abby Womback.

For more information visit https://laidlawltd.com/

ABOUT:

Laidlaw & Company is a New York based independent investment banking and securities brokerage focused on the needs of domestic and international companies, corporate entrepreneurs, institutions and private clients worldwide within sectors such as healthcare, biotechnology, pharmaceuticals.

Contact:
NAME: Leah Luciano
JOB ROLE: Executive Assistant & Director of Human Resources
EMAIL: [email protected]

SOURCE Laidlaw Venture Partners


These press releases may also interest you

at 03:00
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...

at 02:30
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA...

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...

3 jui 2024
YOUR LEGAL RIGHTS MAY BE AFFECTED There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...

3 jui 2024
In a landmark event signaling its ambitious foray into the biopharmaceutical sector, LOTTE BIOLOGICS, under the leadership of CEO Richard W. Lee, held a groundbreaking ceremony for its inaugural plant at the Songdo Bio Campus in Incheon International...



News published on and distributed by: